| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | High-level expression of glycoprotein D by a dominant-negative HSV-1 virus augments its efficacy as a vaccine against HSV-1 infection. | J Invest Dermatol | 2008 | 0.85 |
| 2 | Development of a regulatable oncolytic herpes simplex virus type 1 recombinant virus for tumor therapy. | J Virol | 2010 | 0.75 |